<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31390360</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7404</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>PLoS genetics</Title><ISOAbbreviation>PLoS Genet</ISOAbbreviation></Journal><ArticleTitle>Calcium-responsive transactivator (CREST) toxicity is rescued by loss of PBP1/ATXN2 function in a novel yeast proteinopathy model and in transgenic flies.</ArticleTitle><Pagination><StartPage>e1008308</StartPage><MedlinePgn>e1008308</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1008308</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgen.1008308</ELocationID><Abstract><AbstractText>Proteins associated with familial neurodegenerative disease often aggregate in patients' neurons. Several such proteins, e.g. TDP-43, aggregate and are toxic when expressed in yeast. Deletion of the ATXN2 ortholog, PBP1, reduces yeast TDP-43 toxicity, which led to identification of ATXN2 as an amyotrophic lateral sclerosis (ALS) risk factor and therapeutic target. Likewise, new yeast neurodegenerative disease models could facilitate identification of other risk factors and targets. Mutations in SS18L1, encoding the calcium-responsive transactivator (CREST) chromatin-remodeling protein, are associated with ALS. We show that CREST is toxic in yeast and forms nuclear and occasionally cytoplasmic foci that stain with Thioflavin-T, a dye indicative of amyloid-like protein. Like the yeast chromatin-remodeling factor SWI1, CREST inhibits silencing of FLO genes. Toxicity of CREST is enhanced by the [PIN+] prion and reduced by deletion of the HSP104 chaperone required for the propagation of many yeast prions. Likewise, deletion of PBP1 reduced CREST toxicity and aggregation. In accord with the yeast data, we show that the Drosophila ortholog of human ATXN2, dAtx2, is a potent enhancer of CREST toxicity. Downregulation of dAtx2 in flies overexpressing CREST in retinal ganglion cells was sufficient to largely rescue the severe degenerative phenotype induced by human CREST. Overexpression caused considerable co-localization of CREST and PBP1/ATXN2 in cytoplasmic foci in both yeast and mammalian cells. Thus, co-aggregation of CREST and PBP1/ATXN2 may serve as one of the mechanisms of PBP1/ATXN2-mediated toxicity. These results extend the spectrum of ALS associated proteins whose toxicity is regulated by PBP1/ATXN2, suggesting that therapies targeting ATXN2 may be effective for a wide range of neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sangeun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3898-6197</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, University of Nevada, Reno, Untied States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sei-Kyoung</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, University of Nevada, Reno, Untied States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Naruaki</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-7020-0222</Identifier><AffiliationInfo><Affiliation>Department of Neuropathology, University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Tadafumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwatsubo</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1160-8129</Identifier><AffiliationInfo><Affiliation>Department of Neuropathology, University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shelkovnikova</LastName><ForeName>Tatyana A</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0003-1367-5309</Identifier><AffiliationInfo><Affiliation>Medicines Discovery Institute, Cardiff University, Cardiff, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liebman</LastName><ForeName>Susan W</ForeName><Initials>SW</Initials><Identifier Source="ORCID">0000-0002-5845-4633</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, University of Nevada, Reno, Untied States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MRF_MRF-060-0001-RG-SHELK</GrantID><Acronym>MRF</Acronym><Agency>MRF</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 GM056350</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Genet</MedlineTA><NlmUniqueID>101239074</NlmUniqueID><ISSNLinking>1553-7390</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000622386">ATX2 protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000593752">ATXN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067698">Ataxin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006360">Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C116076">PBP1 protein, S cerevisiae</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011328">Prions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C502810">SS18L1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029701">Saccharomyces cerevisiae Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical><Chemical><RegistryNumber>143012-44-6</RegistryNumber><NameOfSubstance UI="C070972">HsP104 protein, S cerevisiae</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067698" MajorTopicYN="N">Ataxin-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006360" MajorTopicYN="N">Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011328" MajorTopicYN="N">Prions</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012165" MajorTopicYN="N">Retinal Ganglion Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029701" MajorTopicYN="N">Saccharomyces cerevisiae Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31390360</ArticleId><ArticleId IdType="pmc">PMC6699716</ArticleId><ArticleId IdType="doi">10.1371/journal.pgen.1008308</ArticleId><ArticleId IdType="pii">PGENETICS-D-19-00458</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bertram L, Tanzi RE (2005) The genetic epidemiology of neurodegenerative disease. J Clin Invest 115: 1449&#x2013;1457. 10.1172/JCI24761</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI24761</ArticleId><ArticleId IdType="pmc">PMC1137006</ArticleId><ArticleId IdType="pubmed">15931380</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Sayana P, Zhang X, Le W (2013) Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener 8: 28 10.1186/1750-1326-8-28</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, et al. (2010) Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30: 639&#x2013;649. 10.1523/JNEUROSCI.4988-09.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4988-09.2010</ArticleId><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebman SW, Chernoff YO (2012) Prions in yeast. Genetics 191: 1041&#x2013;1072. 10.1534/genetics.111.137760</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.111.137760</ArticleId><ArticleId IdType="pmc">PMC3415993</ArticleId><ArticleId IdType="pubmed">22879407</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner RB (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264: 566&#x2013;569. 10.1126/science.7909170</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7909170</ArticleId><ArticleId IdType="pubmed">7909170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner RB, Masison DC, Edskes HK (1995) [PSI] and [URE3] as yeast prions. Yeast 11: 1671&#x2013;1685. 10.1002/yea.320111609</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/yea.320111609</ArticleId><ArticleId IdType="pubmed">8720070</ArticleId></ArticleIdList></Reference><Reference><Citation>Sondheimer N, Lindquist S (2000) Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell 5: 163&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">10678178</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkatch IL, Bradley ME, Hong JY, Liebman SW (2001) Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 106: 171&#x2013;182. 10.1016/s0092-8674(01)00427-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(01)00427-5</ArticleId><ArticleId IdType="pubmed">11511345</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel BK, Gavin-Smyth J, Liebman SW (2009) The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nat Cell Biol 11: 344&#x2013;349. 10.1038/ncb1843</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1843</ArticleId><ArticleId IdType="pmc">PMC2667906</ArticleId><ArticleId IdType="pubmed">19219034</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki G, Shimazu N, Tanaka M (2012) A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress. Science 336: 355&#x2013;359. 10.1126/science.1219491</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1219491</ArticleId><ArticleId IdType="pubmed">22517861</ArticleId></ArticleIdList></Reference><Reference><Citation>Patino MM, Liu JJ, Glover JR, Lindquist S (1996) Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273: 622&#x2013;626. 10.1126/science.273.5275.622</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.273.5275.622</ArticleId><ArticleId IdType="pubmed">8662547</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z, Park KW, Yu H, Fan Q, Li L (2008) Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. Nat Genet 40: 460&#x2013;465. 10.1038/ng.112</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.112</ArticleId><ArticleId IdType="pmc">PMC2633598</ArticleId><ArticleId IdType="pubmed">18362884</ArticleId></ArticleIdList></Reference><Reference><Citation>Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD (1996) Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 15: 3127&#x2013;3134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC450255</ArticleId><ArticleId IdType="pubmed">8670813</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizhnikov AA, Alexandrov AI, Ryzhova TA, Mitkevich OV, Dergalev AA, et al. (2014) Proteomic screening for amyloid proteins. PLoS One 9: e116003 10.1371/journal.pone.0116003</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0116003</ArticleId><ArticleId IdType="pmc">PMC4280166</ArticleId><ArticleId IdType="pubmed">25549323</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezza JA, Villali J, Sindi SS, Serio TR (2014) Amyloid-associated activity contributes to the severity and toxicity of a prion phenotype. Nat Commun 5: 4384 10.1038/ncomms5384</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5384</ArticleId><ArticleId IdType="pmc">PMC4156856</ArticleId><ArticleId IdType="pubmed">25023996</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z, Li L (2014) Investigating the interactions of yeast prions: [SWI+], [PSI+], and [PIN+]. Genetics 197: 685&#x2013;700. 10.1534/genetics.114.163402</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.114.163402</ArticleId><ArticleId IdType="pmc">PMC4063924</ArticleId><ArticleId IdType="pubmed">24727082</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW (1997) Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics 147: 507&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1208174</ArticleId><ArticleId IdType="pubmed">9335589</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkatch IL, Uptain SM, Outeiro TF, Krishnan R, Lindquist SL, et al. (2004) Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc Natl Acad Sci U S A 101: 12934&#x2013;12939. 10.1073/pnas.0404968101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0404968101</ArticleId><ArticleId IdType="pmc">PMC516497</ArticleId><ArticleId IdType="pubmed">15326312</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebman SW, Bagriantsev SN, Derkatch IL (2006) Biochemical and genetic methods for characterization of [PIN+] prions in yeast. Methods 39: 23&#x2013;34. 10.1016/j.ymeth.2006.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2006.04.010</ArticleId><ArticleId IdType="pubmed">16793281</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkatch IL, Liebman SW (2007) Prion-prion interactions. Prion 1: 161&#x2013;169. 10.4161/pri.1.3.4837</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.1.3.4837</ArticleId><ArticleId IdType="pmc">PMC2634589</ArticleId><ArticleId IdType="pubmed">19164893</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma J, Liebman SW (2013) Exploring the basis of [PIN(+)] variant differences in [PSI(+)] induction. J Mol Biol 425: 3046&#x2013;3059. 10.1016/j.jmb.2013.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.06.006</ArticleId><ArticleId IdType="pmc">PMC3743938</ArticleId><ArticleId IdType="pubmed">23770111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma J, Liebman SW (2013) Variant-specific prion interactions: Complicating factors. Cell Logist 3: e25698 10.4161/cl.25698</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cl.25698</ArticleId><ArticleId IdType="pmc">PMC3891757</ArticleId><ArticleId IdType="pubmed">24475372</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitrenko YA, Gracheva EO, Richmond JE, Liebman SW (2007) Visualization of aggregation of the Rnq1 prion domain and cross-seeding interactions with Sup35NM. J Biol Chem 282: 1779&#x2013;1787. 10.1074/jbc.M609269200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M609269200</ArticleId><ArticleId IdType="pubmed">17121829</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Hong JY, Derkatch IL, Liebman SW (2013) Heterologous gln/asn-rich proteins impede the propagation of yeast prions by altering chaperone availability. PLoS Genet 9: e1003236 10.1371/journal.pgen.1003236</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003236</ArticleId><ArticleId IdType="pmc">PMC3554615</ArticleId><ArticleId IdType="pubmed">23358669</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio TR (2018) [PIN+]ing down the mechanism of prion appearance. FEMS Yeast Res 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5889010</ArticleId><ArticleId IdType="pubmed">29718197</ArticleId></ArticleIdList></Reference><Reference><Citation>Osherovich LZ, Weissman JS (2001) Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell 106: 183&#x2013;194. 10.1016/s0092-8674(01)00440-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(01)00440-8</ArticleId><ArticleId IdType="pubmed">11511346</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan T, Kandola TS, Wu J, Venkatesan S, Ketter E, et al. (2018) Quantifying Nucleation In Vivo Reveals the Physical Basis of Prion-like Phase Behavior. Mol Cell 71: 155&#x2013;168 e157. 10.1016/j.molcel.2018.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.06.016</ArticleId><ArticleId IdType="pmc">PMC6086602</ArticleId><ArticleId IdType="pubmed">29979963</ArticleId></ArticleIdList></Reference><Reference><Citation>Meriin AB, Zhang X, He X, Newnam GP, Chernoff YO, et al. (2002) Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol 157: 997&#x2013;1004. 10.1083/jcb.200112104</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200112104</ArticleId><ArticleId IdType="pmc">PMC2174031</ArticleId><ArticleId IdType="pubmed">12058016</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokhale KC, Newnam GP, Sherman MY, Chernoff YO (2005) Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model. J Biol Chem 280: 22809&#x2013;22818. 10.1074/jbc.M500390200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500390200</ArticleId><ArticleId IdType="pubmed">15824100</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes DL, Lancaster AK, Lindquist S, Halfmann R (2013) Heritable remodeling of yeast multicellularity by an environmentally responsive prion. Cell 153: 153&#x2013;165. 10.1016/j.cell.2013.02.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.02.026</ArticleId><ArticleId IdType="pmc">PMC3759520</ArticleId><ArticleId IdType="pubmed">23540696</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, McCaffery JM, Lindquist S, Gitler AD (2008) A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci U S A 105: 6439&#x2013;6444. 10.1073/pnas.0802082105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802082105</ArticleId><ArticleId IdType="pmc">PMC2359814</ArticleId><ArticleId IdType="pubmed">18434538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju S, Tardiff DF, Han H, Divya K, Zhong Q, et al. (2011) A yeast model of FUS/TLS-dependent cytotoxicity. PLoS Biol 9: e1001052 10.1371/journal.pbio.1001052</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1001052</ArticleId><ArticleId IdType="pmc">PMC3082520</ArticleId><ArticleId IdType="pubmed">21541368</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryndushkin D, Ihrke G, Piermartiri TC, Shewmaker F (2012) A yeast model of optineurin proteinopathy reveals a unique aggregation pattern associated with cellular toxicity. Mol Microbiol 86: 1531&#x2013;1547. 10.1111/mmi.12075</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/mmi.12075</ArticleId><ArticleId IdType="pubmed">23078282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryndushkin D, Shewmaker F (2011) Modeling ALS and FTLD proteinopathies in yeast: an efficient approach for studying protein aggregation and toxicity. Prion 5: 250&#x2013;257. 10.4161/pri.17229</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.17229</ArticleId><ArticleId IdType="pmc">PMC4012400</ArticleId><ArticleId IdType="pubmed">22052354</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gregorio SE, Duennwald ML (2018) Yeast as a model to study protein misfolding in aged cells. FEMS Yeast Res 18.</Citation><ArticleIdList><ArticleId IdType="pubmed">29905793</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurahashi H, Ishiwata M, Shibata S, Nakamura Y (2008) A regulatory role of the Rnq1 nonprion domain for prion propagation and polyglutamine aggregates. Mol Cell Biol 28: 3313&#x2013;3323. 10.1128/MCB.01900-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01900-07</ArticleId><ArticleId IdType="pmc">PMC2423166</ArticleId><ArticleId IdType="pubmed">18332119</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Hong JY, Arslan F, Kanneganti V, Patel B, et al. (2017) Overexpression of the essential Sis1 chaperone reduces TDP-43 effects on toxicity and proteolysis. PLoS Genet 13: e1006805 10.1371/journal.pgen.1006805</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006805</ArticleId><ArticleId IdType="pmc">PMC5460882</ArticleId><ArticleId IdType="pubmed">28531192</ArticleId></ArticleIdList></Reference><Reference><Citation>Treusch S, Hamamichi S, Goodman JL, Matlack KE, Chung CY, et al. (2011) Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science 334: 1241&#x2013;1245. 10.1126/science.1213210</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1213210</ArticleId><ArticleId IdType="pmc">PMC3281757</ArticleId><ArticleId IdType="pubmed">22033521</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Ratia K, Ba M, Valencik M, Liebman SW (2016) Inhibition of Abeta42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs. Microb Cell 3: 53&#x2013;64. 10.15698/mic2016.02.476</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/mic2016.02.476</ArticleId><ArticleId IdType="pmc">PMC5349104</ArticleId><ArticleId IdType="pubmed">28357335</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal SL, Wang X, Demirci FY, Barmada MM, Ganguli M, et al. (2012) Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease. Am J Neurodegener Dis 1: 191&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3560458</ArticleId><ArticleId IdType="pubmed">22984654</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, et al. (2009) Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 41: 308&#x2013;315. 10.1038/ng.300</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.300</ArticleId><ArticleId IdType="pmc">PMC2683786</ArticleId><ArticleId IdType="pubmed">19182805</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, et al. (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466: 1069&#x2013;1075. 10.1038/nature09320</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Auburger G, Sen NE, Meierhofer D, Basak AN, Gitler AD (2017) Efficient Prevention of Neurodegenerative Diseases by Depletion of Starvation Response Factor Ataxin-2. Trends Neurosci 40: 507&#x2013;516. 10.1016/j.tins.2017.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2017.06.004</ArticleId><ArticleId IdType="pubmed">28684172</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley MD, Thomas A, Gitler AD (2014) Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis. Neurobiol Aging 35: 936 e931-934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3880650</ArticleId><ArticleId IdType="pubmed">24269018</ArticleId></ArticleIdList></Reference><Reference><Citation>Gispert S, Kurz A, Waibel S, Bauer P, Liepelt I, et al. (2012) The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis 45: 356&#x2013;361. 10.1016/j.nbd.2011.08.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.08.021</ArticleId><ArticleId IdType="pubmed">21889984</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Zhu Y, Chen-Plotkin AS, Clay-Falcone D, McCluskey L, et al. (2011) PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats. PLoS One 6: e17951 10.1371/journal.pone.0017951</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017951</ArticleId><ArticleId IdType="pmc">PMC3066214</ArticleId><ArticleId IdType="pubmed">21479228</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E, Vandenberghe N, Moigneu C, Boillee S, Couratier P, et al. (2014) Genetic analysis of SS18L1 in French amyotrophic lateral sclerosis. Neurobiol Aging 35.</Citation><ArticleIdList><ArticleId IdType="pubmed">24360741</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesi A, Staahl BT, Jovicic A, Couthouis J, Fasolino M, et al. (2013) Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat Neurosci 16: 851&#x2013;855. 10.1038/nn.3412</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3412</ArticleId><ArticleId IdType="pmc">PMC3709464</ArticleId><ArticleId IdType="pubmed">23708140</ArticleId></ArticleIdList></Reference><Reference><Citation>Middeljans E, Wan X, Jansen PW, Sharma V, Stunnenberg HG, et al. (2012) SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes. PLoS One 7: e33834 10.1371/journal.pone.0033834</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0033834</ArticleId><ArticleId IdType="pmc">PMC3307773</ArticleId><ArticleId IdType="pubmed">22442726</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodges C, Kirkland JG, Crabtree GR (2016) The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer. Cold Spring Harb Perspect Med 6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968166</ArticleId><ArticleId IdType="pubmed">27413115</ArticleId></ArticleIdList></Reference><Reference><Citation>Staahl BT, Tang J, Wu W, Sun A, Gitler AD, et al. (2013) Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways. J Neurosci 33: 10348&#x2013;10361. 10.1523/JNEUROSCI.1258-13.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1258-13.2013</ArticleId><ArticleId IdType="pmc">PMC3685834</ArticleId><ArticleId IdType="pubmed">23785148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kukharsky MS, Quintiero A, Matsumoto T, Matsukawa K, An H, et al. (2015) Calcium-responsive transactivator (CREST) protein shares a set of structural and functional traits with other proteins associated with amyotrophic lateral sclerosis. Mol Neurodegener 10: 20 10.1186/s13024-015-0014-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0014-y</ArticleId><ArticleId IdType="pmc">PMC4428507</ArticleId><ArticleId IdType="pubmed">25888396</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan A, Liu Y (2005) A multifunctional domain of the calcium-responsive transactivator (CREST) that inhibits dendritic growth in cultured neurons. J Biol Chem 280: 24738&#x2013;24743. 10.1074/jbc.M504018200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M504018200</ArticleId><ArticleId IdType="pubmed">15866867</ArticleId></ArticleIdList></Reference><Reference><Citation>Louvion JF, Havaux-Copf B, Picard D (1993) Fusion of GAL4-VP16 to a steroid-binding domain provides a tool for gratuitous induction of galactose-responsive genes in yeast. Gene 131: 129&#x2013;134. 10.1016/0378-1119(93)90681-r</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-1119(93)90681-r</ArticleId><ArticleId IdType="pubmed">8370533</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW (1996) Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 144: 1375&#x2013;1386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1207691</ArticleId><ArticleId IdType="pubmed">8978027</ArticleId></ArticleIdList></Reference><Reference><Citation>Fushimi K, Long C, Jayaram N, Chen X, Li L, et al. (2011) Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy. Protein Cell 2: 141&#x2013;149. 10.1007/s13238-011-1014-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1014-5</ArticleId><ArticleId IdType="pmc">PMC3093303</ArticleId><ArticleId IdType="pubmed">21327870</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SK, Arslan F, Kanneganti V, Barmada SJ, Purushothaman P, et al. (2018) Overexpression of a conserved HSP40 chaperone reduces toxicity of several neurodegenerative disease proteins. Prion 12: 16&#x2013;22. 10.1080/19336896.2017.1423185</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1423185</ArticleId><ArticleId IdType="pmc">PMC5871033</ArticleId><ArticleId IdType="pubmed">29308690</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW (1995) Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268: 880&#x2013;884. 10.1126/science.7754373</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7754373</ArticleId><ArticleId IdType="pubmed">7754373</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z, Zhang Y, Li L (2015) The Yeast Prion [SWI(+)] Abolishes Multicellular Growth by Triggering Conformational Changes of Multiple Regulators Required for Flocculin Gene Expression. Cell Rep 13: 2865&#x2013;2878. 10.1016/j.celrep.2015.11.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.11.060</ArticleId><ArticleId IdType="pmc">PMC4704862</ArticleId><ArticleId IdType="pubmed">26711350</ArticleId></ArticleIdList></Reference><Reference><Citation>Halme A, Bumgarner S, Styles C, Fink GR (2004) Genetic and epigenetic regulation of the FLO gene family generates cell-surface variation in yeast. Cell 116: 405&#x2013;415. 10.1016/s0092-8674(04)00118-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(04)00118-7</ArticleId><ArticleId IdType="pubmed">15016375</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Derkatch IL, Liebman SW (2001) The relationship between visible intracellular aggregates that appear after overexpression of Sup35 and the yeast prion-like elements [PSI(+)] and [PIN(+)]. Mol Microbiol 39: 37&#x2013;46. 10.1046/j.1365-2958.2001.02224.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2958.2001.02224.x</ArticleId><ArticleId IdType="pubmed">11123686</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterfield TF, Jackson SM, Pallanck LJ (2002) A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. Genetics 162: 1687&#x2013;1702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1462369</ArticleId><ArticleId IdType="pubmed">12524342</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncharoff DK, Du Z, Li L (2018) A brief overview of the Swi1 prion-[SWI+]. FEMS Yeast Res 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6001882</ArticleId><ArticleId IdType="pubmed">29905794</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkatch IL, Bradley ME, Masse SV, Zadorsky SP, Polozkov GV, et al. (2000) Dependence and independence of [PSI(+)] and [PIN(+)]: a two-prion system in yeast? EMBO J 19: 1942&#x2013;1952. 10.1093/emboj/19.9.1942</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/19.9.1942</ArticleId><ArticleId IdType="pmc">PMC305693</ArticleId><ArticleId IdType="pubmed">10790361</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentealba RA, Udan M, Bell S, Wegorzewska I, Shao J, et al. (2010) Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. J Biol Chem 285: 26304&#x2013;26314. 10.1074/jbc.M110.125039</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.125039</ArticleId><ArticleId IdType="pmc">PMC2924052</ArticleId><ArticleId IdType="pubmed">20554523</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi H, Okamura K, Bauer PO, Furukawa Y, Shimizu H, et al. (2008) RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells. J Biol Chem 283: 6489&#x2013;6500. 10.1074/jbc.M705306200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M705306200</ArticleId><ArticleId IdType="pubmed">18167354</ArticleId></ArticleIdList></Reference><Reference><Citation>Satpute-Krishnan P, Langseth SX, Serio TR (2007) Hsp104-dependent remodeling of prion complexes mediates protein-only inheritance. PLoS Biol 5: e24 10.1371/journal.pbio.0050024</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0050024</ArticleId><ArticleId IdType="pmc">PMC1779812</ArticleId><ArticleId IdType="pubmed">17253904</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidel G, Meierhofer D, Sen NE, Guenther A, Krobitsch S, et al. (2017) Quantitative Global Proteomics of Yeast PBP1 Deletion Mutants and Their Stress Responses Identifies Glucose Metabolism, Mitochondrial, and Stress Granule Changes. J Proteome Res 16: 504&#x2013;515. 10.1021/acs.jproteome.6b00647</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.6b00647</ArticleId><ArticleId IdType="pubmed">27966978</ArticleId></ArticleIdList></Reference><Reference><Citation>Olbertz JH (2012) The protein SS18L1 is a potent suppressor of polyQ mediated huntingtin aggregation and toxicity. Dissertation Adviser Dr. Erich Wanker.</Citation></Reference><Reference><Citation>Kapeli K, Pratt GA, Vu AQ, Hutt KR, Martinez FJ, et al. (2016) Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat Commun 7: 12143 10.1038/ncomms12143</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12143</ArticleId><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, Hart MP, Shorter J, DeJesus-Hernandez M, Erion R, et al. (2011) A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A 108: 20881&#x2013;20890. 10.1073/pnas.1109434108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109434108</ArticleId><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130&#x2013;133. 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr., Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205&#x2013;1208. 10.1126/science.1166066</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323: 1208&#x2013;1211. 10.1126/science.1165942</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic A, Paul JW, 3rd, Gitler AD (2016) Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia. J Neurochem 138 Suppl 1: 134&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">27087014</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold HC, Jackson KL, Arora A, Weskamp K, Tank EM, et al. (2018) TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci Rep 8: 4606 10.1038/s41598-018-22858-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22858-w</ArticleId><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryndushkin D, Wickner RB, Shewmaker F (2011) FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis. Protein Cell 2: 223&#x2013;236. 10.1007/s13238-011-1525-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1525-0</ArticleId><ArticleId IdType="pmc">PMC4875312</ArticleId><ArticleId IdType="pubmed">21452073</ArticleId></ArticleIdList></Reference><Reference><Citation>Armakola M, Higgins MJ, Figley MD, Barmada SJ, Scarborough EA, et al. (2012) Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet 44: 1302&#x2013;1309. 10.1038/ng.2434</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2434</ArticleId><ArticleId IdType="pmc">PMC3510335</ArticleId><ArticleId IdType="pubmed">23104007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, et al. (2011) Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol 9: e1000614 10.1371/journal.pbio.1000614</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakthavachalu B, Huelsmeier J, Sudhakaran IP, Hillebrand J, Singh A, et al. (2018) RNP-Granule Assembly via Ataxin-2 Disordered Domains Is Required for Long-Term Memory and Neurodegeneration. Neuron 98: 754&#x2013;766 e754. 10.1016/j.neuron.2018.04.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.04.032</ArticleId><ArticleId IdType="pubmed">29772202</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YR, King OD, Shorter J, Gitler AD (2013) Stress granules as crucibles of ALS pathogenesis. J Cell Biol 201: 361&#x2013;372. 10.1083/jcb.201302044</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S, Wang J, Papadopoulos DK, Richter D, Pozniakovsky A, et al. (2018) RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science 360: 918&#x2013;921. 10.1126/science.aar7366</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar7366</ArticleId><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Zhang P, Freibaum BD, Kim NC, Kolaitis RM, et al. (2016) Genetic interaction of hnRNPA2B1 and DNAJB6 in a Drosophila model of multisystem proteinopathy. Hum Mol Genet 25: 936&#x2013;950. 10.1093/hmg/ddv627</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv627</ArticleId><ArticleId IdType="pmc">PMC4754048</ArticleId><ArticleId IdType="pubmed">26744327</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z, Shewmaker F, Pandey UB (2016) Stress granules at the intersection of autophagy and ALS. Brain Res 1649: 189&#x2013;200. 10.1016/j.brainres.2016.05.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.05.022</ArticleId><ArticleId IdType="pmc">PMC5055418</ArticleId><ArticleId IdType="pubmed">27181519</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker LA, Huang B, Bieri G, Ma R, Knowles DA, et al. (2017) Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544: 367&#x2013;371. 10.1038/nature22038</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22038</ArticleId><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Zhang P, Kim HJ, Mitrea DM, Sarkar M, et al. (2016) C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell 167: 774&#x2013;788 e717. 10.1016/j.cell.2016.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoles DR, Meera P, Schneider MD, Paul S, Dansithong W, et al. (2017) Antisense oligonucleotide therapy for spinocerebellar ataxia type 2. Nature 544: 362&#x2013;366. 10.1038/nature22044</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22044</ArticleId><ArticleId IdType="pmc">PMC6625650</ArticleId><ArticleId IdType="pubmed">28405024</ArticleId></ArticleIdList></Reference><Reference><Citation>Swisher KD, Parker R (2010) Localization to, and effects of Pbp1, Pbp4, Lsm12, Dhh1, and Pab1 on stress granules in Saccharomyces cerevisiae. PLoS One 5: e10006 10.1371/journal.pone.0010006</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010006</ArticleId><ArticleId IdType="pmc">PMC2848848</ArticleId><ArticleId IdType="pubmed">20368989</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahara T, Maeda T (2012) Transient sequestration of TORC1 into stress granules during heat stress. Mol Cell 47: 242&#x2013;252. 10.1016/j.molcel.2012.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2012.05.019</ArticleId><ArticleId IdType="pubmed">22727621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gietz RD, Schiestl RH (2007) High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc 2: 31&#x2013;34. 10.1038/nprot.2007.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.13</ArticleId><ArticleId IdType="pubmed">17401334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi O, Yoshimoto H, Sone H (1999) Analysis of the genes activated by the FLO8 gene in Saccharomyces cerevisiae. Curr Genet 36: 256&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">10591965</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeke JD, LaCroute F, Fink GR (1984) A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol Gen Genet 197: 345&#x2013;346. 10.1007/bf00330984</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00330984</ArticleId><ArticleId IdType="pubmed">6394957</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, Gitler AD, Lindquist S (2007) A suite of Gateway cloning vectors for high-throughput genetic analysis in Saccharomyces cerevisiae. Yeast 24: 913&#x2013;919. 10.1002/yea.1502</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/yea.1502</ArticleId><ArticleId IdType="pmc">PMC2190539</ArticleId><ArticleId IdType="pubmed">17583893</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman F FG, Hicks JB (1986) Methods in Yeast Genetics; Sherman F FG, Hicks JB, editor. Plainview, New York: Cold Spring Harbor Press.</Citation></Reference><Reference><Citation>Sikorski RS, Hieter P (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122: 19&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1203683</ArticleId><ArticleId IdType="pubmed">2659436</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagriantsev SN, Gracheva EO, Richmond JE, Liebman SW (2008) Variant-specific [PSI+] infection is transmitted by Sup35 polymers within [PSI+] aggregates with heterogeneous protein composition. Mol Biol Cell 19: 2433&#x2013;2443. 10.1091/mbc.E08-01-0078</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E08-01-0078</ArticleId><ArticleId IdType="pmc">PMC2397312</ArticleId><ArticleId IdType="pubmed">18353968</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratford M (1989) Yeast flocculation:Calcium specificity. Yeast 5: 487&#x2013;496.</Citation></Reference><Reference><Citation>Brachmann CB, Davies A, Cost GJ, Caputo E, Li J, et al. (1998) Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14: 115&#x2013;132. 10.1002/(SICI)1097-0061(19980130)14:2&lt;115::AID-YEA204&gt;3.0.CO;2-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0061(19980130)14:2&lt;115::AID-YEA204&gt;3.0.CO;2-2</ArticleId><ArticleId IdType="pubmed">9483801</ArticleId></ArticleIdList></Reference><Reference><Citation>Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, et al. (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285: 901&#x2013;906. 10.1126/science.285.5429.901</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.285.5429.901</ArticleId><ArticleId IdType="pubmed">10436161</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan JR, Muhlrad D, Parker R (2008) P bodies promote stress granule assembly in Saccharomyces cerevisiae. J Cell Biol 183: 441&#x2013;455. 10.1083/jcb.200807043</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200807043</ArticleId><ArticleId IdType="pmc">PMC2575786</ArticleId><ArticleId IdType="pubmed">18981231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilliker A, Gao Z, Jankowsky E, Parker R (2011) The DEAD-box protein Ded1 modulates translation by the formation and resolution of an eIF4F-mRNA complex. Mol Cell 43: 962&#x2013;972. 10.1016/j.molcel.2011.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.08.008</ArticleId><ArticleId IdType="pmc">PMC3268518</ArticleId><ArticleId IdType="pubmed">21925384</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>